Article
Publicly Available
Frontmatter
Published/Copyright:
November 14, 2024
Published Online: 2024-11-14
©2024 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
- Research Articles
- Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis
- Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery
- Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)
Articles in the same Issue
- Frontmatter
- Review
- Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
- Research Articles
- Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis
- Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery
- Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)
